271 related articles for article (PubMed ID: 29619514)
1. Surgical Indication for Advanced Intrahepatic Cholangiocarcinoma According to the Optimal Preoperative Carbohydrate Antigen 19-9 Cutoff Value.
Yamamoto Y; Sugiura T; Todaka A; Okamura Y; Ito T; Ashida R; Kakuda Y; Nakanuma Y; Uesaka K
World J Surg; 2018 Oct; 42(10):3331-3340. PubMed ID: 29619514
[TBL] [Abstract][Full Text] [Related]
2. Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma.
Cai WK; Lin JJ; He GH; Wang H; Lu JH; Yang GS
Int J Clin Exp Pathol; 2014; 7(11):7890-8. PubMed ID: 25550829
[TBL] [Abstract][Full Text] [Related]
3. Surgical Indication for Advanced Gallbladder Cancer Considering the Optimal Preoperative Carbohydrate Antigen 19-9 Cutoff Value.
Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Ohgi K; Uesaka K
Dig Surg; 2020; 37(5):390-400. PubMed ID: 32272472
[TBL] [Abstract][Full Text] [Related]
4. Elevated perioperative serum CA 19-9 levels are independent predictors of poor survival in patients with resectable cholangiocarcinoma.
Kondo N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Sasaki H; Sueda T
J Surg Oncol; 2014 Sep; 110(4):422-9. PubMed ID: 24889968
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer.
Yamashita S; Passot G; Aloia TA; Chun YS; Javle M; Lee JE; Vauthey JN; Conrad C
Br J Surg; 2017 Feb; 104(3):267-277. PubMed ID: 28052308
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing the prognosis of patients with intrahepatic cholangiocarcinoma.
Liu ZH; Chen Z; Ma LL; Li XH; Wang LX
Acta Gastroenterol Belg; 2012 Jun; 75(2):215-8. PubMed ID: 22870785
[TBL] [Abstract][Full Text] [Related]
7. Indications for laparoscopic liver resection of mass-forming intrahepatic cholangiocarcinoma.
Kinoshita M; Kanazawa A; Takemura S; Tanaka S; Kodai S; Shinkawa H; Shimizu S; Murata A; Nishio K; Hamano G; Ito T; Tsukamoto T; Kubo S
Asian J Endosc Surg; 2020 Jan; 13(1):46-58. PubMed ID: 30924307
[TBL] [Abstract][Full Text] [Related]
8. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
9. A novel prognostic system combining carbonic anhydrase II and preoperative CA19-9 for intrahepatic cholangiocarcinoma after curative resection.
Zhang J; Huang Q; Yang Y; Zhang J; Fang X; Yang Y; Liang H; Wang W; Wang Y
Cancer; 2023 Apr; 129(7):1030-1040. PubMed ID: 36625486
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.
Miwa S; Miyagawa S; Kobayashi A; Akahane Y; Nakata T; Mihara M; Kusama K; Soeda J; Ogawa S
J Gastroenterol; 2006 Sep; 41(9):893-900. PubMed ID: 17048054
[TBL] [Abstract][Full Text] [Related]
11. Survival analysis of intrahepatic cholangiocarcinoma after resection.
Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM
Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987
[TBL] [Abstract][Full Text] [Related]
12. Negative impact of preoperative platelet-lymphocyte ratio on outcome after hepatic resection for intrahepatic cholangiocarcinoma.
Chen Q; Dai Z; Yin D; Yang LX; Wang Z; Xiao YS; Fan J; Zhou J
Medicine (Baltimore); 2015 Apr; 94(13):e574. PubMed ID: 25837750
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer.
Kato Y; Takahashi S; Gotohda N; Konishi M
J Gastrointest Surg; 2016 Aug; 20(8):1435-43. PubMed ID: 27250990
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of preoperative CA19-9 and lymph node metastasis in intrahepatic cholangiocarcinoma.
Asaoka T; Kobayashi S; Hanaki T; Iwagami Y; Tomimaru Y; Akita H; Noda T; Gotoh K; Takeda Y; Tanemura M; Doki Y; Eguchi H
Surg Today; 2020 Oct; 50(10):1176-1186. PubMed ID: 32221659
[TBL] [Abstract][Full Text] [Related]
15. A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.
Rhee H; Kim MJ; Park YN; An C
Eur Radiol; 2019 Jun; 29(6):3111-3121. PubMed ID: 30560357
[TBL] [Abstract][Full Text] [Related]
16. Predictive score for identifying intrahepatic cholangiocarcinoma patients without lymph node metastasis: a basis for omitting lymph node dissection.
Miura Y; Ashida R; Ohgi K; Yamada M; Kato Y; Otsuka S; Aramaki T; Kakuda Y; Uesaka K; Sugiura T
HPB (Oxford); 2024 Jun; 26(6):800-807. PubMed ID: 38461071
[TBL] [Abstract][Full Text] [Related]
17. Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma.
Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
World J Surg; 2007 Oct; 31(10):2016-22. PubMed ID: 17687597
[TBL] [Abstract][Full Text] [Related]
18. Intrahepatic cholangiocarcinoma: a clinicopathologic study of 37 resected cases.
Zhu HF; Li J; Huang L; Yan YQ
Hepatogastroenterology; 2013; 60(122):263-7. PubMed ID: 23574653
[TBL] [Abstract][Full Text] [Related]
19. Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology.
Itamoto T; Asahara T; Katayama K; Nakahara H; Fukuda T; Yano M; Hino H; Nakahara M; Dohi K; Shimamoto F
Hepatogastroenterology; 2001; 48(40):1129-33. PubMed ID: 11490816
[TBL] [Abstract][Full Text] [Related]
20. Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis.
Zhang XF; Xue F; Dong DH; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Lv Y; Pawlik TM
Ann Surg; 2021 Dec; 274(6):e1187-e1195. PubMed ID: 31972643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
